These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 11806306)

  • 1. [Myocardial infarction and iloprost in a patient with scleroderma].
    Marroun I; Fialip J; Deleveaux I; André M; Lamaison D; Cabane J; Piette JC; Eschalier A; Aumaitre O
    Therapie; 2001; 56(5):630-2. PubMed ID: 11806306
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombotic events in patients with systemic sclerosis treated with iloprost.
    Tedeschi A; Meroni PL; Del Papa N; Salmaso C; Boschetti C; Miadonna A
    Arthritis Rheum; 1998 Mar; 41(3):559-60. PubMed ID: 9506585
    [No Abstract]   [Full Text] [Related]  

  • 3. [Digital necrosis in scleroderma].
    Fain O
    Rev Prat; 2007 Feb; 57(4):359. PubMed ID: 17455736
    [No Abstract]   [Full Text] [Related]  

  • 4. [Iloprost therapy in systemic sclerosis].
    Bali G; Aberer E
    Hautarzt; 2003 Sep; 54(9):845-51. PubMed ID: 12955262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement in cholesterol emboli syndrome after iloprost therapy.
    Elinav E; Chajek-Shaul T; Stern M
    BMJ; 2002 Feb; 324(7332):268-9. PubMed ID: 11823357
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term evaluation of lung function in patients affected by scleroderma treated with cyclic iloprost infusions.
    Caramaschi P; Biasi D; Ferrari M; Volpe A; Martinelli N; Carletto A; Dal Forno P; Bambara LM
    Rheumatol Int; 2005 May; 25(4):250-4. PubMed ID: 14963694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffuse cutaneous systemic sclerosis treated with intravenous iloprost.
    Foti C; Cassano N; Conserva A; Coviello C; De Meo M; Vena GA
    Clin Exp Dermatol; 2004 May; 29(3):321-3. PubMed ID: 15115528
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical response to iloprost treatment in a patient with cholesterol ateroembolic renal disease].
    Rodríguez Gómez MA; Heras M; Molina Ordas A; Fernández-Reyes MJ; Sánchez R; Alvarez-Ude F
    Nefrologia; 2009; 29(5):494-6. PubMed ID: 19820771
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiac surgery in patients with heparin-induced thrombocytopenia using preoperatively determined dosages of iloprost.
    Antoniou T; Kapetanakis EI; Theodoraki K; Rellia P; Thanopoulos A; Kotiou M; Zarkalis D; Alivizatos P
    Heart Surg Forum; 2002; 5(4):354-7. PubMed ID: 12538117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative detection and management of immune heparin-induced thrombocytopenia in patients undergoing heart surgery with iloprost.
    Palatianos GM; Foroulis CN; Vassili MI; Matsouka P; Astras GM; Kantidakis GH; Iliopoulou E; Melissari EN
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):548-54. PubMed ID: 14762367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of cholesterol emboli syndrome treated with iloprost].
    Karadağ B; Döventaş A; Ozkan H; Erdinçler DS; Beğer T; Yüksel H
    Anadolu Kardiyol Derg; 2007 Mar; 7(1):76-8. PubMed ID: 17347083
    [No Abstract]   [Full Text] [Related]  

  • 12. Connective tissue disease: Reflections on the EULAR recommendations for the treatment of systemic sclerosis.
    Pope JE
    Nat Rev Rheumatol; 2017 Mar; 13(3):134-136. PubMed ID: 28053333
    [No Abstract]   [Full Text] [Related]  

  • 13. Antioxidant effect of Iloprost: current knowledge and therapeutic implications for systemic sclerosis.
    Erre GL; Passiu G
    Reumatismo; 2009; 61(2):90-7. PubMed ID: 19633795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iloprost treatment in systemic sclerosis: comment on the concise communication by Tedeschi et al.
    Braun J; Sieper J; Riemekasten G; Hiepe F
    Arthritis Rheum; 1999 Jan; 42(1):196-8. PubMed ID: 9920036
    [No Abstract]   [Full Text] [Related]  

  • 15. Iloprost in the management of leg ulcer in polyarteritis nodosa. A case report.
    Biancari F; Kantonen I; Peltomaa R; Lepäntalo M
    Int Angiol; 1999 Dec; 18(4):335-6. PubMed ID: 10811524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperbaric oxygen therapy in a case of cholesterol crystal embolization.
    Gurgo A; Valenti V; Paneni F; Passerini J; Di Vavo M; Calvieri C; Cacchi C; Bartolazzi A; Sabani A; Volpe M
    Am J Emerg Med; 2011 Jul; 29(6):694.e3-6. PubMed ID: 20708883
    [No Abstract]   [Full Text] [Related]  

  • 17. Combined administration of nitric oxide gas and iloprost during cardiopulmonary bypass reduces platelet dysfunction: a pilot clinical study.
    Chung A; Wildhirt SM; Wang S; Koshal A; Radomski MW
    J Thorac Cardiovasc Surg; 2005 Apr; 129(4):782-90. PubMed ID: 15821644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iloprost for scleroderma.
    Constans T; Diot E; Lasfargues G
    Ann Intern Med; 1991 Apr; 114(7):606. PubMed ID: 1705762
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of iloprost on adhesion molecules and F1 + 2 in peripheral ischemia.
    Mazzone A; Faggioli P; Cusa C; Stefanin C; Rondena M; Morelli B
    Eur J Clin Invest; 2002 Dec; 32(12):882-8. PubMed ID: 12534446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transmural myocardial infarction in a patient with systemic scleroderma].
    Shabanov VA; Sorokin RA; Shmyrova VA
    Klin Med (Mosk); 1991 Jan; 69(1):98-9. PubMed ID: 2023413
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.